The Journal of Bone and Joint Surgery (American) 86:1065-1076 (2004)
© 2004 The Journal of Bone and Joint Surgery, Inc.
Transmission and Prevention of Occupational Infections in Orthopaedic Surgeons
Kwok Chuen Wong, MBChB, FRCSEd(Orth)1 and
Kwok Sui Leung, MD, FRCSEd1
1 Department of Orthopaedics and Traumatology, Chinese University of Hong Kong,
5/F, Clinical Science Building, Prince of Wales Hospital, Hong Kong Special
Administrative Region, China. E-mail address for K.C. Wong:
skcwong{at}ort.cuhk.edu.hk
Investigation performed at the Department of Orthopaedics and
Traumatology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong
Kong, China
The authors did not receive grants or outside funding in support of their
research or preparation of this manuscript. They did not receive payments or
other benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, educational
institution, or other charitable or nonprofit organization with which the
authors are affiliated or associated.
 |
Abstract
|
|---|
Microorganisms are transmitted in hospitals mainly by contact, droplet, and
airborne routes.
Orthopaedic surgeons have a substantial occupational risk of contracting a
blood-borne infection because of frequent handling of sharp instruments and
objects during operative procedures.
Aerosolization means the formation of aerosols and droplets when
blood or other body fluids are mechanically disturbed. Smaller particles
(<5 µm) will remain suspended in air. Pathogens that can survive in
these small airborne particles may cause infection if they are inhaled.
Aerosol-generating procedures in patients with tuberculosis or severe acute
respiratory syndrome (SARS) may facilitate airborne transmission.
The Hospital Infection Control Practices Advisory Committee and the Centers
for Disease Control and Prevention have established guidelines for isolation
precautions in hospitals.
 |
Introduction
|
|---|
Surgeons and health-care workers have always had a high risk of exposure to
blood-borne diseases as a result of their occupation. Orthopaedic surgeons
have substantial occupational exposure to blood and the risk of blood-borne
infection because of frequent handling of sharp instruments, metal objects
(e.g., wire), and bone fragments during operative
procedures1-4.
The purpose of this review is to discuss the risk of occupational
blood-borne infection and the means of disease transmission by contact,
droplet, and airborne routes in orthopaedic surgery. The role of
aerosolization in the facilitation of disease transmission will be analyzed.
Severe acute respiratory syndrome (SARS), the recently recognized and highly
contagious respiratory infection, will be discussed in detail. Finally,
precautionary measures to protect against occupational infection will be
reviewed.
 |
Means of Transmission of Microorganisms
|
|---|
Understanding the means of transmission of infectious diseases is very
important in the prevention of occupational transmission of pathogens.
Microorganisms are transmitted in hospitals mainly by contact, droplet, and
airborne routes.
Contact Transmission
This is the most important and frequent mode of transmission of nosocomial
infection. There are two types of contact transmission: direct and indirect.
Direct-contact transmission involves direct body-to-body contact with the
transfer of microorganisms during routine care of patients. Indirect-contact
transmission is the transmission of pathogens by contact with contaminated
objects such as dressings, needles, and instruments.
Droplet Transmission
Droplets are primarily generated by patients during coughing, sneezing, and
talking and during the performance of certain procedures such as suctioning
and bronchoscopy. Transmission occurs when droplets containing microorganisms
generated from the infected patient are propelled a short distance through the
air and deposited on the skin or mucosal surface of the health-care worker.
Severe acute respiratory syndrome (SARS) is one of the illnesses transmitted
by droplets, and it has spread worldwide and raised global concern.
Airborne Transmission
Aerosolization means the formation of aerosols and droplets when
blood or another body fluid is mechanically disturbed. Small particles (<5
µm) can remain suspended in air and can be dispersed widely by air
currents. Airborne transmission can occur by dissemination of these small
particles if they contain pathogens, and inhalation of these particles may
result in infection. Mycobacterium tuberculosis is an example of a
typical microorganism transmitted by this airborne route.
 |
Contact Transmission
|
|---|
Health-care workers and particularly surgeons are at risk for occupational
transmission of blood-borne pathogens, such as hepatitis-B virus, hepatitis-C
virus, and human immunodeficiency virus (HIV). Infection with blood-borne
pathogens occurs mainly by contact transmissioni.e., percutaneous or
mucocutaneous exposure to blood-borne pathogens. Percutaneous exposure is due
to needlesticks or cuts from other sharp instruments, implanted materials, or
bone fragments contaminated with the blood of infected patients. Mucocutaneous
exposure occurs through contact of the mucous membrane of the eyes, nose, or
mouth or contact of the skin with the blood of infected patients. Percutaneous
injuries are a substantial risk for health care workers, with 5520
percutaneous injuries reported by fifteen hospitals participating in the
Centers for Disease Control and Prevention National Surveillance System for
Hospital Health Care Workers (NaSH) between June 1995 and July
19995. Of 4569
percutaneous injuries, 2826 (62%) were associated with hollow-bore
needles5. Of 3057
percutaneous injuries, approximately 38% occurred during use of needles and
42% occurred after use and before disposal of
needles5.
The risk of percutaneous and mucocutaneous exposure for orthopaedic
surgeons and operating room personnel has also been investigated. Gerberding
et al.3 discussed
the risk of exposure to blood at San Francisco General Hospital after
analyzing data on 1307 consecutive operations. They found that percutaneous
injury occurred in twenty-two operations (1.7%) and mucocutaneous exposure
occurred in sixty-two (4.7%). The risk of exposure was higher when procedures
lasted more than three hours and blood loss exceeded 300 mL.
Quebbeman et al.4
studied the prevalence of percutaneous injuries and mucocutaneous exposure
during 234 operations involving 1763 operating room personnel. They found that
percutaneous injuries occurred in thirty-five operations (15%) and
mucocutaneous exposure, in 118 (50%). In addition, orthopaedic surgeons had
increased face and neck contamination due to splattering of blood from power
tools and the use of irrigation fluids.
In a study in which a mail survey was sent to 1200 orthopaedic surgeons in
the United Kingdom and 800 (67%) responded, 511 surgeons reported that they
had sustained needlestick injuries or contamination of the eyes with patients'
body fluid within the past
month6.
In another investigation, orthopaedic surgeons attending the annual meeting
of the American Academy of Orthopaedic Surgeons in 1991 were surveyed about
occupational blood contact and HIV
infection2. Of 7147
orthopaedic surgeons at the meeting, 3420 (47.9%) participated in the survey;
2989 (87.4%) reported cutaneous contact with blood and 1340 (39.2%) reported
percutaneous contact with blood in the previous month. One hundred and nine
surgeons (3.2%) reported percutaneous contact with the blood of a patient
known to have HIV infection or acquired immunodeficiency syndrome (AIDS) in
their career. Among 108 participants with nonoccupational HIV risk factors,
only two were positive for the HIV antibody. Among 3267 participants without
nonoccupational HIV risk factors, none was positive for the HIV antibody.
Surgeons sustain most percutaneous injuries when they are suturing. The
index finger of the nondominant hand is often injured because of the surgeon's
use of his or her fingers to hold tissue while suturing or during blind
suturing7,8.
The occupational risk of infection with blood-borne pathogens depends on a
variety of factors9
as presented in Table I.
 |
Hepatitis-B Virus
|
|---|
The risk of transmission of hepatitis-B virus during a single percutaneous
exposure of an unvaccinated person to blood infected with the virus ranges
from 6% to
30%10,11.
The risk associated with mucocutaneous exposure has not been quantified but
may be higher than the risk with other blood-borne pathogens. Hepatitis-B
virus can survive in dried blood at room temperature on environmental surfaces
for at least one
week12. The
potential for transmission of hepatitis-B virus through contact with
environmental surfaces has been demonstrated in investigations of outbreaks of
infections with hepatitis-B virus among patients and staff of hemodialysis
units13,14.
Hepatitis-B virus has been found in saliva but is usually undetectable in
urine and feces15.
Transmission of the virus by human bites is therefore possible and has been
documented16. The
risk of infection after exposure depends on the status of the hepatitis-Be
antigen of the source individual. The presence of hepatitis-Be antigen in the
serum is associated with higher levels of circulating virus in the blood and
therefore with greater infectivity of an individual who is positive for the
antigen11.
Vaccination against hepatitis B is a safe and effective way to prevent
hepatitis-B infection. It is strongly recommended that all surgeons receive
the vaccine. Testing for antibody response should be completed one to two
months after the third vaccine dose. A protective antibody response is 10
mIU/mL. Vaccine-induced hepatitis-B surface antibodies decline gradually over
time17. However,
immune memory remains intact indefinitely following immunization, and people
with declining levels of hepatitis-B surface antibodies are still protected
against the
disease18.
Therefore, neither booster doses of hepatitis-B vaccine nor periodic testing
for hepatitis-B surface antibodies is necessary for previously immunized
surgeons19. The
hepatitis-B vaccination status and the vaccine-response status of the exposed
surgeon will aid in determining appropriate postexposure prophylaxis. The
mainstay of postexposure prophylaxis is hepatitis-B vaccine, but in some
settings the addition of hepatitis-B immunoglobulin provides better
protection. Table II summarizes
the recommendations of the Centers for Disease Control and Prevention for
postexposure prophylaxis after parenteral exposure to hepatitis-B virus.
 |
Hepatitis-C Virus
|
|---|
The prevalence of anti-hepatitis-C virus seroconversion (an indication of
infection) after an accidental percutaneous exposure to blood infected with
the virus averages 1.8% and ranges from 0% to
7%20. The
prevalence is lower than that associated with exposure to hepatitis-B virus.
Transmission rarely occurs from exposure of the mucous membrane to blood. We
are aware of only two case reports demonstrating transmission of hepatitis-C
virus following occupational conjunctival exposure to
blood21,22.
To our knowledge, transmission of hepatitis-C virus during exposure of intact
or nonintact skin to the blood of patients with hepatitis-C virus infection
has never been documented. In addition, hepatitis-C virus RNA has not been
detected in the urine, feces, or saliva from patients with chronic hepatitis-C
virus infection23.
The risk of transmission of hepatitis-C virus during exposure to the above
secretions has not been quantified but is expected to be low. Currently,
neither vaccines nor medications for postexposure treatment are available to
prevent hepatitis-C virus infection.
 |
Human Immunodeficiency Virus (HIV)
|
|---|
The risk of HIV infection due to a single percutaneous injury is estimated
to be 0.3% (95% confidence interval = 0.2% to
0.5%)24,25.
It is higher than the estimated risk of infection after exposure of a mucosal
membrane (0.09%) (95% confidence interval = 0.006% to
0.5%)26.
Transmission of HIV due to exposure involving small amounts of blood on intact
skin has not been documented, to our knowledge. In one prospective study of
2712 cases of exposure of intact skin to HIV, no infections were
found27. Therefore,
a small amount of HIV on intact skin probably poses no risk. In one
case-control study of health-care workers who had percutaneous exposure to
HIV, the risk of HIV infection was shown to increase with exposure to a larger
amount of HIV-infected
blood28. Four
factors were also found to be associated with an increased risk of HIV
transmission in that study: (1) deep injury, (2) visible blood on the device
that caused the injury, (3) a procedure that involved a large-gauge
hollow-bore needle directly placed in a vein or artery, and (4) exposure to a
patient with acquired immunodeficiency syndrome or a high plasma viral
burden28.
HIV has been found in the saliva from some AIDS patients, although in lower
quantities than in the
plasma29. HIV has
not been recovered from the sweat of HIV-infected persons. The risk of
transmission through exposure to these fluids is probably considerably lower
than the risk with exposure to HIV-infected
blood27. The
relative infectivity of HIV varies among individuals and over time for a
single
individual30.
Unlike the case for hepatitis-B virus infection, there is currently no readily
available laboratory test with which to assess increased HIV infectivity.
Although medications for postexposure prophylaxis against HIV infection are
available, data regarding their efficacy are limited. Zidovudine
(azidothymidine [AZT]), a nucleoside analogue reverse transcriptase inhibitor,
is the only drug that has been studied and shown to reduce the risk of HIV
transmission following occupational exposure. A retrospective case-control
study on health-care workers revealed an 81% (95% confidence interval = 48% to
94%) reduction in the risk of infection with the use of AZT after percutaneous
exposure28.
However, a combination of antiviral medications, rather than a one-drug AZT
regimen, is now recommended (based on data derived from treatment of
HIV-infected patients) for its theoretical advantage of more effective
prevention of HIV
transmission31. The
Centers for Disease Control and Prevention (CDC) recommended a basic two-drug
regimen of AZT and lamivudine when there is a risk of infection. A three-drug
regimen, with the addition of a protease inhibitor such as indinavir, is
recommended when there is a higher risk of
transmission31. All
of these antiviral drugs are potentially toxic and have been associated with
side effects. As most instances of occupational exposure to HIV do not result
in HIV transmission, the risks and benefits of prescribing postexposure
prophylaxis must be carefully considered.
 |
Droplet and Airborne Transmission
|
|---|
Tuberculosis is a respiratory infection caused by Mycobacterium
tuberculosis and is spread by airborne transmission. The SARS virus is
predominantly spread by droplets shed from respiratory secretions of infected
individuals. Although airborne transmission does not seem to be a major route
for the spread of the SARS virus, there have been anecdotal reports that
aerosol-generating procedures might facilitate transmission of the virus in
some cases32. As a
result, it is crucial to understand the role of aerosolization of body fluids
in facilitating disease transmission.
 |
Aerosolization
|
|---|
Aerosols are defined as fine particles with a diameter of 10 µm that
are suspended in a gas. Droplets are much larger particles that have a
definite trajectory pathway away from the site of
production33.
Aerosols and droplets can be formed when blood or another body fluid is
mechanically disturbed. They are thus generated by some patients during
coughing and sneezing; they can also be generated by the use of pulsed
irrigation or power tools during operative procedures. The more violent the
disturbance, the more likely is the formation of aerosols and smaller
droplets. Larger particles ( 5 µm in diameter) settle rapidly under
gravity, whereas smaller particles (<5 µm in diameter) settle slowly and
remain in the air.
If a suspension of microorganisms is aerosolized, the liquid component will
dry up rapidly, leaving the microbial contents as droplet nuclei suspended in
air. These droplet nuclei containing microorganisms, usually referred to as
infected airborne particles, can be dispersed by air currents generated by
ventilation or movement of people and can reach a long distance from an
infected source. Particles of <5 µm in diameter are more likely to reach
the alveoli of the lung than are larger particles, which tend to be trapped in
the upper respiratory tract. Therefore, airborne transmission can occur by
dissemination of these infected airborne particles if a susceptible host
inhales them. Contact transmission of infection may also occur if these
aerosols come into contact with mucous membranes or small
wounds34. Thus,
special air handling and ventilation are required to prevent this airborne
infection.
Droplets generated from infected persons do not travel far, usually 3
ft ( 0.9 m) in air, and are deposited on environmental surfaces or on the
skin or mucous membranes of individuals. Any pathogens that can survive in
these droplets pose a risk of infection.
Mucocutaneous exposure due to droplet transmission should not be confused
with airborne transmission by
aerosols35 because
droplets do not remain suspended in air. Special air handling or ventilation
is thus not required to prevent droplet transmission.
Particles of various sizes are produced during coughing and sneezing.
Pathogens capable of surviving in small droplet nuclei (<5 µm in
diameter) then become airborne. To be capable of surviving in small droplet
nuclei, the pathogen must be durable and resistant to drying. Therefore, when
a patient with tuberculosis coughs, he or she spreads the disease by the
airborne route. When a patient with influenza coughs, he or she spreads the
disease by droplet transmission. SARS is thought to spread predominantly by
droplet transmission.
Although it is known that blood-borne pathogens can be transmitted through
mucous membrane exposure, there is a lack of evidence suggesting that
blood-borne pathogens can be transmitted by inhalation of aerosolized blood.
Hepatitis-B virus infection is not transmitted by inhalation of aerosolized
blood36,37.
However, studies have shown that common orthopaedic power tools are capable of
generating respirable blood containing
aerosols38-40.
These aerosols can be spread all over the operating room, contaminating the
animate and inanimate environmental
surfaces39. A study
in which cascade impactors were mounted in the breathing zones of primary and
assistant surgeons demonstrated that the surgeons were exposed to respirable
blood containing aerosols in the operating
rooms41. An
experimental study demonstrated that HIV can remain viable in cool aerosols
generated by power
tools42. This may
cause HIV transmission to surgeons exposed to aerosols generated during
operations on HIV-infected patients. Therefore, aerosolized blood-borne
pathogens may lead to airborne infection if the aerosols containing the
pathogens are inhaled. Additional work is required to determine whether this
aerosol amounts to a significant occupational risk in operating theaters.
Precautionary measures against contact with infectious aerosols and
droplets have to be mandatory during procedures in which high-speed
orthopaedic power tools are used. Every person present during the surgery
should wear personal protective apparel, including surgical gloves, a
water-resistant surgical gown with long sleeves, a surgical mask, and
full-face protection with a face-shield. Additional respiratory protective
equipment should be used when surgeons operate on patients with tuberculosis
or SARS. It is recommended that the surgery be performed by experienced
surgeons and anesthetists and sufficiently trained personnel to reduce
operative time and the duration of exposure to infectious aerosols. Use of
diathermy and power tools should be kept to a minimum. Wound irrigation with
bulb syringes is preferred to pulsed irrigation. It is critical to remove and
dispose of protective apparel and respiratory devices without contaminating
oneself at the conclusion of the procedure. It is essential to wash the hands
prior to touching the face, eyes, or nose after removal of protective apparel.
Most operating rooms undergo up to twenty room-air exchanges per hour.
Therefore, any infectious aerosol particles should be removed quickly.
However, the entire operating theater must be properly decontaminated between
cases, as pathogens within droplets can survive for hours outside the body on
inanimate environmental surfaces.
 |
Tuberculosis
|
|---|
Tuberculosis is the prototype disease for the study of airborne infection
because it is transmitted effectively through the air when people in close
contact with a person with active disease inhale droplet nuclei containing
tubercle bacilli (1 to 5 µm in diameter).
Investigations of outbreaks of tuberculosis can illustrate several
important principles of disease transmission. One study showed that inadequate
ventilation resulted in recirculation of contaminated air and positive
tuberculin conversion in 35% of sixty
employees43.
Tuberculosis may also spread through inhalation of aerosols generated during
the care of a tuberculous skin
lesion44 or during
procedures such as irrigation of tuberculous abscesses of the hip and thigh
with saline
solution45. These
cases demonstrated that nonpulmonary tuberculosis could also be contagious in
certain settings. Other aerosol-generating procedures such as nasotracheal
suctioning can amplify the risk of transmission, as shown by an outbreak in an
emergency room, where an intubated man was present for only four hours and
spread infection to at least sixteen of the 112 emergency room
staff46. Managing
unsuspected cases of tuberculosis also results in a higher risk of tuberculin
conversion47. Early
identification and a high index of suspicion of the disease are essential for
preventing the disease.
 |
Severe Acute Respiratory Syndrome (SARS)
|
|---|
SARS is a newly recognized, severe febrile respiratory illness caused by a
previously unknown coronavirus, SARS-associated coronavirus (SARS-CoV). The
condition primarily affects people who come into close contact with infected
patients as well as health-care workers who look after the patients. This
highly contagious respiratory infection can affect healthy people and can
frequently result in rapid deterioration and progress to respiratory failure.
It is also a potentially fatal disease. In an epidemiological study of 1425
patients with SARS, the mortality rate was reported to range from 13.2% for
patients younger than sixty years of age to 43.3% for those older than sixty
years of age48.
SARS was spread worldwide to thirty countries by travelers in 2003, prompting
the World Health Organization to issue a global alert for the first time in
more than a decade.
The primary mode of spread is by droplet transmission. It occurs when
individuals come into close contact with contaminated respiratory droplets
that were shed from secretions of an infected person during coughing or
sneezing49.
SARS-CoV can be found in urine and feces from infected
individuals50. New
evidence suggests that the virus survives in feces and urine at room
temperature for at least one to two days. Heating to 56°C kills the virus,
as does exposure to many commonly used
disinfectants51.
SARS-CoV can thus be transmitted if people touch their own mucous membrane
with their contaminated hands. Blood can also contain SARS-CoV, and viremia
has been detected up to ten days after the onset of symptoms in patients with
SARS52. There is a
theoretical risk that SARS-CoV can behave like other blood-borne pathogens and
spread the disease by contact transmission. However, we are not aware of any
study in which this possibility was investigated. More work is required to
determine whether this means of transmission of SARS actually exists.
Originally, SARS was not thought to spread by the airborne route. However,
the outbreak in Hong Kong that originated at the Metropole
Hotel53 and the
Amoy Gardens54
indicates that airborne transmission is possible in special settings.
Aerosolization of body fluids of an infected person may facilitate the
transmission. However, there is a lack of evidence suggesting that SARS can be
transmitted secondarily by aerosolization of blood.
It has been shown that the viral load in the nasopharyngeal aspirates of
SARS patients does not peak until ten days after the onset of symptoms. At
fifteen days, it decreases to the levels measured during the initial
presentation to the hospital (mean, 3.2 days after the onset of symptoms). In
the stool, the viral load appears to peak at fourteen days after the onset of
symptoms50. The
infectivity of SARS-CoV might be variable over time, even during the
symptomatic phase of the disease, and transmission may be more likely during
the later stages of the disease.
The World Health Organization categorizes SARS into suspected and probable
cases according to the case
definition55. In
brief, the case definition of SARS includes a fever of 38°C during the
two days before presentation; coughing, shortness of breath, malaise, or
headache; new pulmonary infiltrates on chest radiographs or high-resolution
computed tomography scans; a history of contact with an infected person;
absence of an alternative diagnosis to explain the clinical presentation; and
laboratory evidence of SARS-CoV infection. Therefore, SARS is diagnosed
according to clinical and radiographic features, contact history, and
laboratory tests. However, existing reverse transcriptase-polymerase chain
reaction (RT-PCR) tests for SARS-CoV are not very accurate, especially during
the early phase of the disease when the viral load is low. The positivity of
the test thus depends on the timing of the collection of the specimens.
Interpretation of these assays must be performed carefully because of the
possibility of false-negative results, which are frequent early in the course
of the infection, and false-positive results, which are especially important
concerns. Existing antibody tests of seroconversion are generally useful only
after three weeks have elapsed following the disease onset, which is far too
late to be of much practical use. Therefore, in the absence of a reliable and
rapid laboratory test, the diagnosis of SARS is based purely on clinical and
radiographic features and a positive contact history.
This may cause some difficulties in identifying SARS, particularly in
geriatric patients. Early symptoms of SARS such as fever, malaise, and
headache are nonspecific and are associated with other, more common illnesses.
Frail elderly patients with multiple coexisting chronic diseases might have no
fever at
presentation56,57,
leading to a delay in diagnosis. Therefore, the initial diagnosis depends
largely on a history of exposure risk. However, geriatric patients may not be
able to provide a precise contact history. Also, some patients may be
reluctant to reveal a true contact history because of a fear of social stigma
or quarantine of their families or
friends58.
In the presence of infection, frail geriatric patients tend to have a
history of falls, confusion, incontinence, and poor feeding at presentation.
Focus on the management of injuries or fractures resulting from falls by
geriatric patients may distract orthopaedic surgeons from investigating the
medical cause of the injury, such as
SARS59.
Identification of SARS in this group thus requires a high index of suspicion.
Unrecognized cases of SARS may lead to future
outbreaks60.
No vaccines have yet been developed and no antiviral treatment has been
shown to be effective against SARS. Success in controlling disease
transmission relies on early identification of suspected cases, proper
isolation, and implementation of and adherence to infection control
precautions61.
 |
Prevention of Occupational Infection Among Orthopaedic Surgeons
|
|---|
The Hospital Infection Control Practices Advisory Committee (HICPAC) and
the Centers for Disease Control and Prevention have established guidelines for
isolation precautions in
hospitals62.
Because pathogens and host factors are sometimes more difficult to eliminate,
a more feasible way of controlling the spread of disease is by taking
isolation precautions to interrupt the spread directly at the level of
transmission.
There are two tiers of HICPAC Isolation Precautions. The first tier is
Standard Precautions. They are designed for the care of all inpatients,
irrespective of their underlying diseases or presumed infection status. Blood
and all other body fluids of patients are considered to be potentially
infectious. The second tier is Transmission-Based Precautions. They are used
for patients known or suspected to be infected or colonized with transmissible
or epidemiologically important pathogens for which additional precautions
beyond Standard Precautions are required to prevent nosocomial transmission.
Transmission-Based Precautions are based on the knowledge of routes of
transmission. They are classified as Contact Precautions, Droplet Precautions,
and Airborne Precautions. The precautions may be combined for diseases that
have multiple modes of transmission such as SARS. They are also expected to be
used in addition to Standard Precautions.
While it is impossible to apply Transmission-Based Precautions to all
patients, early identification of certain infectious diseases that warrant the
additional use of these enhanced precautions is crucial. The risk of
transmission of infection will certainly be minimized if precautions based on
the diagnosis of infectious diseases can be implemented early.
As a result, Standard Precautions should be applied whenever there is a
risk of exposure to blood or other body fluids of any patient. Contact
Precautions should also be taken when health-care workers are caring for
patients with blood-borne pathogens, and Droplet or Airborne Precautions
should be added when they are dealing with patients with a disease such as
SARS or tuberculosis.
A summary of Standard Precautions is provided in
Table III. The reader is
referred to the Centers for Disease Control and Prevention for complete
recommendations with regard to both Standard and Transmission-Based
Precautions62.
The following sections will address the important issues pertinent to
dealing with infectious diseases in orthopaedic practice. Only salient
features of the Standard Precautions and Transmission-Based Precautions will
be highlighted.
Hand-Washing
Hand-washing is the single most important and simplest step taken by
surgeons to prevent disease transmission. It must be actively reinforced. Hand
antisepsis reduces the incidence of nosocomial
infection63-65.
A recent study showed that increased hand-washing by hospital personnel
reduced the acquisition of various health-care-associated
pathogens65. Both
this study and
another66 showed
that the prevalence of infection decreased as adherence to hand hygiene
measures improved.
Studies have also indicated that scrubbing for five minutes reduces
bacterial counts as effectively as does scrubbing for ten
minutes67,68.
Scrubbing for two to three minutes could reduce bacterial counts to acceptable
levels as
well69,70.
Protocols for hand antisepsis for surgical personnel have required
scrubbing with a brush. However, the use of a brush may cause skin damage and
lead to shedding of bacteria from the hands. Studies have also demonstrated
that a brush is not necessary to reduce bacterial counts on the hands of
surgical personnel to acceptable
levels71-73.
Therefore, brushes may do more harm than they contribute to cleaning. Their
use should be restricted to cleaning the fingernails only.
Clinical trials have compared the effect of hand-washing with plain soap
and water with the effect of some form of hand antisepsis on infection rates.
Nosocomial infection rates were lower when antiseptic hand-washing was
performed by hospital
personnel74,75.
An alcohol-based surgical hand-rub is effective for hand
antisepsis76-78.
In one prospective, randomized trial of 4387 consecutive operations, hand
rubbing with aqueous alcoholic solution preceded by a one-minute nonantiseptic
hand wash was shown to be as effective as a traditional surgical hand-scrub
with antiseptic soap (4% povidone iodine or 4% chlorhexidine gluconate) in
preventing surgical site
infection76. The
authors concluded that hand rubbing with liquid aqueous alcoholic solution can
be used safely as an alternative to the traditional surgical hand scrub. In
another study, alcohol preparations were even more effective than
povidone-iodine or chlorhexidine for the surgical
scrub77. As a
result, the presurgical scrub has been replaced in many European countries by
the alcoholic rub. Table IV
summarizes the characteristics of common hand antiseptic agents.
The Healthcare Infection Control Practices Advisory Committee and the Hand
Hygiene Task Force of the Centers for Disease Control and Prevention have
given the following recommendations for surgical hand
antisepsis79:
- Remove debris from underneath the fingernails with use of a nail cleaner
under running water.
- Perform hand antisepsis with use of either an antimicrobial soap or an
alcohol-based hand-rub that has persistent activity before performing surgical
procedures.
- Scrub hands and forearms for the length of time recommended by the
manufacturer of the hand cleaner, usually two to six minutes. Long scrub times
(e.g., ten minutes) are not necessary.
- Before applying an alcohol-based surgical hand-scrub product with
persistent activity, prewash hands and forearms with a non-antimicrobial soap
and dry hands and forearms completely. After applying the alcohol-based
product as recommended, allow hands and forearms to dry thoroughly before
donning sterile gloves.
Gloves
Wearing gloves is fundamental to both Standard and Transmission-Based
Precautions. Gloves provide barrier protection to surgeons and reduce the risk
of exposure to blood-borne pathogens as recommended by the Occupational Safety
and Health Administration
(OSHA)80. In the
2002 Cochrane Database Systematic Review of double gloving, the findings from
eighteen randomized, controlled trials showed that double gloving reduces
surgical cross infection. Wearing a glove liner between two pairs of latex
gloves or wearing cloth outer gloves to perform joint replacement surgery
decreases perforations to the innermost gloves more than does the use of
double latex
gloves81. One
biomechanical study comparing double latex gloves with single latex
orthopaedic gloves indicated that double gloves might be a desirable
alternative to single orthopaedic
gloves82. The most
common concern that surgeons have about wearing double gloves is loss of touch
sensitivity. Watts et al. found a significant difference (p < 0.05) in
tactile sensation when similar pressure was applied by surgeons wearing single
or double gloves83.
However, the authors of the study concluded that this difference could be
minimized by applying firmer pressure when wearing double gloves.
Masks, Protective Eyewear, and Face-Shields
Masks, eye protection, and face-shields are essential Contact and Droplet
Precautions. They form an effective barrier that protects surgeons from
exposure to infectious droplets and splashes. Eye protection is critical for
orthopaedic surgeons because of the frequent use of power tools, which spray
body fluid. In a prospective study of conjunctival contamination during common
orthopaedic operations, forty-three (65%) of sixty-six goggles worn by
surgeons were contaminated. The contamination rate of the protective flaps at
the sides of the goggles was relatively low (5%), suggesting that ordinary
spectacles, which are more convenient and comfortable than standard goggles,
provide adequate protection during routine
use84. Therefore,
orthopaedic surgeons working in a high-risk environment must protect
themselves against possible conjunctival contamination by wearing a mask with
eye protection, goggles, or a face-shield or by minimizing the spraying of
body fluid in the operating theater during the use of power tools.
Gowns
Sterile surgical gowns are used to create a barrier between the surgical
field and potential sources of bacteria. They reduce wound contamination and
clinical infection rates in clean
surgery85. It has
been estimated that, in joint replacement operations, 98% of bacteria found in
patients' wounds come directly or indirectly from the air in the operating
theater86. Studies
have compared the effectiveness of occlusive clothing with that of body
exhaust suits in reducing airborne bacterial contamination during joint
replacement
operations87-89.
Body exhaust suits did not reduce the airborne bacterial contamination in the
operating theater significantly more than did occlusive clothing (p >
0.05).
Different types of surgical occlusive clothing can offer different degrees
of barrier protection to surgeons. Surgical gown fabrics with higher water and
oil repellency and smaller pore sizes generally provide greater barrier
protection90. In
one comparative study, the amount of blood strike-through and bacterial
penetration was lower with polypropylene disposable surgical gowns than it was
with polyester-wood pulp disposable gowns or reusable, cotton
gowns91.
Body exhaust suits or air exhaust systems with portable high-efficiency
particulate filters are designed to protect patients from contamination by
surgical teams. They can protect surgeons only against pathogens spread by
contact or droplet transmission, not against those spread by airborne
transmission. Additional respiratory protective equipment should be worn if
there is a risk of airborne infection.
 |
Strategies to Prevent Airborne Infection with Tuberculosis
|
|---|
The concept of reducing the risk of occupational exposure to airborne
transmission of tuberculosis has evolved into three levels of control:
administrative, engineering, and personal respiratory
protection92.
The most important component is administrative control, which affects the
largest number of persons. This involves implementation of administrative
measures, such as maintaining a high index of suspicion, rapid identification,
isolation, diagnostic evaluation, and treatment of the disease.
The second level of control is the use of environmental or engineering
procedures, which eliminate the risk of exposure to health-care workers
without reliance on their efforts. Examples include negative-pressure
isolation rooms with more than twelve air exchanges per hour to remove
potentially infected air from the environment, air cleaning with use of
high-efficiency particulate air filters, or ultraviolet germicidal
irradiation.
The last level is the use of personal respiratory protection equipment. On
a hospital-wide basis, it is less effective than administrative and
engineering control because respiratory protection can only reduce, not
eliminate, the risk in the few areas where exposure to tuberculosis can still
occur (e.g., rooms in which patients with known or suspected tuberculosis are
being isolated and treatment rooms in which cough-inducing or
aerosol-generating procedures are performed on such patients). These
strategies also provide guidelines for dealing with other diseases with
possible airborne transmission, such as SARS.
 |
Personal Respiratory Protective Equipment
|
|---|
Surgical Masks
Surgical masks (Fig. 1) are
generally worn by health-care workers to provide protection against pathogens
spread by droplet transmission. However, they provide inadequate respiratory
protection against pathogens with airborne transmission or during high-risk
procedures that generate aerosols. They may have up to 50% filter leakage and
are not sufficiently tight-fitting to prevent inhalation of aerosols.
Therefore, they can provide protection only against larger
droplets93,94.
N95 Respirators
An N95 respirator (Fig. 2)
or an equivalent or higher-standard respirator should be worn for all contact
with patients with tuberculosis or SARS. N95 respirators are air-purifying
respirators, which protect against pathogens with droplet or airborne
transmission. They fulfill the filtering efficiency criteria of the National
Institute for Occupational Safety and Health (NIOSH) N95 standard. They are
capable of filtering with at least 95% efficiency both larger droplets and
most penetrating aerosols of 0.3 µm in
diameter95.
Air-purifying respirators require the user to generate negative pressure to
"suck air through" the filtering material of the respirators.
Facial hair prevents a good seal as will use of the wrong size of respirator.
Before one of these respirators is used, it should be fit-tested according to
the manufacturer's recommendations. Users should also check the fit of the
respirator every time they wear them by placing both hands over the respirator
and exhaling vigorously to determine if the respirator seals tightly to the
face. Users should replace the respirator immediately if breathing becomes
difficult, the respirator becomes damaged, or a proper face fit cannot be
maintained. Respirators can be worn for six to eight hours continuously before
being replaced. The outer surface should not be touched, and it must be
replaced if it becomes grossly contaminated or wet. Models with exhalation
valves should not be used in areas where a clean or sterile field is
required.
Powered Air-Purifying Respirators
Nonoperative contact with patients with tuberculosis or SARS can be made
with use of an N95 respirator, but an invasive procedure or an
aerosol-generating procedure on such patients requires use of a highly
protective respirator such as a powered air-purifying respirator
(Fig. 3). It has been shown
that, when a patient with tuberculous infection underwent a procedure that
generated respiratory aerosols, operating personnel had to wear a powered
air-purifying respirator in order to provide sufficient respiratory
protection96. The
Centers for Disease Control and Prevention recommended that the same principle
be applied to patients with
SARS32. At this
time, there is inadequate information to determine whether this enhanced
respiratory protection will reduce the transmission of SARS.

View larger version (77K):
[in this window]
[in a new window]
|
Fig. 3 Power air-purifying respirator. The respirator has a motor-driven fan that
draws contaminated room air into a high-efficiency particulate air (HEPA)
filter with a 99.97% filtering efficiency. The purified air is then delivered
under positive pressure to the hood by means of a snap-in hose connector that
is secured into the back of the hood. An N95 respirator is worn underneath the
powered air-purifying respirator to provide maximum protection and protect the
sterile surgical field from the respiratory secretions of the user.
|
|
In view of the possible airborne transmission of infectious aerosols from
patients with tuberculosis or SARS, all operating room personnel should wear a
powered air-purifying respirator with a hood that covers the head, neck, and
shoulder regions during high-risk aerosol-generating procedures. The powered
air-purifying respirator has a motor-driven fan that draws contaminated room
air into a high-efficiency particulate air (HEPA) filter with a 99.97%
filtering efficiency. The purified air is then delivered under positive
pressure to the hood by means of a snap-in hose connector that is secured into
the back of the hood. The exhaled air of the user escapes at the lower end of
the hood, which is covered by an overlying waterproof gown. An N95 respirator
is worn underneath the powered air-purifying respirator to provide maximum
protection and protect the sterile surgical field from the respiratory
secretions of the user.
Operating personnel should be trained and rehearsed on how to use the
respiratory protective devices correctly because improper use will lead to a
false sense of security. Dizziness or claustrophobia may be experienced when
wearing a powered air-purifying respirator.
 |
Overview
|
|---|
Orthopaedic surgeons are frequently exposed to blood and are at a high risk
for blood-borne infection. The SARS outbreak has alerted us to the need for
reviewing our current practices of infection control. Understanding the means
of transmission of infectious diseases is very important in preventing
occupational transmission of pathogens. There is a concern about secondary
infection by aerosolization of blood or other body fluids during the use of
power tools. Epidemiological studies on the risk of this means of transmission
will be very difficult because of the need to control all risk factors in
order to establish the relative infectivity of the patients compared with that
of a control group not generating aerosols. Because of this current
uncertainty, extra precautions should be adopted during aerosol-generating
procedures.
 |
Acknowledgments
|
|---|
NOTE: The authors acknowledge the help of Dr. Henry Ho for his
work in editing the manuscript.
 |
References
|
|---|
- Panlilio AL, Foy DR, Edwards JR, Bell
DM, Welch BA, Parrish CM, Culver DH, Lowry PQ, Jarvis WR, Perlino CA.
Blood contacts during surgical procedures. JAMA.1991; 265:1533
-7.[Abstract/Free Full Text]
- Tokars JI, Chamberland ME, Schable
CA, Culver DH, Jones M, McKibben PS, Bell DM. A survey of occupational
blood contact and HIV infection among orthopedic surgeons. The American
Academy of Orthopaedic Surgeons Sero-survey Study Committee.
JAMA. 1992;268:489
-94.[Abstract/Free Full Text]
- Gerberding JL, Littell C, Tarkington
A, Brown A, Schecter WP. Risk of exposure of surgical personnel to
patients' blood during surgery at San Francisco General Hospital. N
Engl J Med. 1990;322:1788
-93.[Abstract]
- Quebbeman EJ, Telford GL, Hubbard S,
Wadsworth K, Hardman B, Goodman H, Gottlieb MS. Risk of blood
contamination and injury to operating room personnel. Ann
Surg. 1991;214:614
-20.[Medline]
- Centers for Disease Control and
Prevention. The national surveillance system for hospital
health care workers. Summary report for data collected from June 1995 through
July 1999.
www.cdc.gov/ncidod/hip/nash/report99.pdf.
- Porteous MJ. Operating practices
of and precautions taken by orthopaedic surgeons to avoid infection with HIV
and hepatitis B virus during surgery. BMJ.1990; 301:167
-9.
- Johanet H, Antona D, Bouvet E.
[Risks of accidental exposure to blood in the operating room. Results of a
multicenter prospective study. Groupe d'Etude sur les Risques d'Exposition au
Sang]. Ann Chir.1995; 49: 403-10.
French.[Medline]
- Nelsing S, Nielsen TL, Nielsen
JO. Percutaneous blood exposure among Danish doctors: exposure mechanisms
and strategies for prevention. Eur J Epidemiol.1997; 13:387
-93.[Medline]
- Centers for Disease Control and
Prevention. Exposure to blood. What health-care workers need
to know. 2002.
www.cdc.gov/ncidod/hip/blood/exp_blood.htm.
- Seeff LB, Wright EC, Zimmerman HJ,
Alter HJ, Dietz AA, Felsher BF, Finkelstein JD, Garcia-Font P, Gerin JL,
Greenlee HB, Hamilton J, Holland PV, Kaplan PM, Kiernan T, Koff RS, Leevy CM,
McAuliffe VJ, Nath N, Purcell RH, Schiff ER, Schwartz CC, Tamburro CH,
Vlahcevic Z, Zemel R, Zimmon DS. Type B hepatitis after needle-stick
exposure: prevention with hepatitis B immune globulin. Final report of the
Veterans Administration Cooperative Study. Ann Intern
Med. 1978;88:285
-93.
- Alter HJ, Seeff LB, Kaplan PM,
McAuliffe VJ, Wright EC, Gerin JL, Purcell RH, Holland PV, Zimmerman HJ.
Type B hepatitis: the infectivity of blood positive for e antigen and DNA
polymerase after accidental needlestick exposure. N Engl J
Med. 1976;295:909
-13.[Abstract]
- Bond WW, Favero MS, Petersen NJ,
Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after
drying and storage for one week. Lancet.1981; 1:550
-1.[Medline]
- Hennekens CH.
Hemodialysis-associated hepatitis. An outbreak among hospital personnel.
JAMA. 1973;225:407
-8.[Abstract/Free Full Text]
- Snydman DR, Bryan JA, Macon EJ, Gregg
MB. Hemodialysis-associated hepatitis: report of an epidemic with further
evidence on mechanisms of transmission. Am J
Epidemiol. 1976;104:563
-70.[Abstract/Free Full Text]
- Villarejos VM, Visona KA, Gutierrez
A, Rodriguez A. Role of saliva, urine and feces in the transmission of
type B hepatitis. N Engl J Med.1974; 291:1375
-8.
- Cancio-Bello TP, de Medina M, Shorey
J, Valledor MD, Schiff ER. An institutional outbreak of hepatitis B
related to a human biting carrier. J Infect Dis.1982; 146:652
-6.[Medline]
- Stevens CE, Toy PT, Taylor PE, Lee T,
Yip HY. Prospects for control of hepatitis B virus infection: implications
of childhood vaccination and long-term protection.
Pediatrics.1992; 90:170
-3.[Abstract/Free Full Text]
- Hadler SC, Margolis HS. Hepatitis
B immunization: vaccine types, efficacy, and indications for immunization.
Curr Clin Top Infect Dis.1992; 12:282
-308.[Medline]
- Centers for Disease Control and
Prevention. Immunization of health-care workers:
recommendations of the Advisory Committee on Immunization Practices (ACIP) and
the Hospital Infection Control Practices Advisory Committee (HICPAC).
MMWR Recomm Rep.1997; 46:1
-42.[Medline]
- Centers for Disease Control and
Prevention. Recommendations for prevention and control of
hepatitis C virus (HCV) infection and HCV-related chronic disease.
MMWR Recomm Rep.1998; 47:1
-39.[Medline]
- Sartori M, La Terra G, Aglietta M,
Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood
splash into conjunctiva. Scand J Infect Dis.1993; 25:270
-1.[Medline]
- Ippolito G, Puro V, Petrosillo N, De
Carli G, Micheloni G, Magliano E. Simultaneous infection with HIV and
hepatitis C virus following occupational conjunctival blood exposure.
JAMA. 1998;280:28
.[Free Full Text]
- Hsu HH, Wright TL, Luba D, Martin M,
Feinstone SM, Garcia G, Greenberg HB. Failure to detect hepatitis C virus
genome in human secretions with the polymerase chain reaction.
Hepatology.1991; 14:763
-7.[Medline]
- Gerberding JL. Incidence and
prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C
virus, and cytomegalovirus among health care personnel at risk for blood
exposure: final report from a longitudinal study. JInfect
Dis. 1994;170:1410
-7.[Medline]
- Ippolito G, Puro V, Heptonstall J,
Jagger J, De Carli G, Petrosillo N. Occupational human immunodeficiency
virus infection in health care workers: worldwide cases through September
1997. Clin Infect Dis.1999; 28:365
-83.[Medline]
- Ippolito G, Puro V, De Carli G.
The risk of occupational human immunodeficiency virus infection in health care
workers. Italian Multicenter Study. The Italian Study Group on Occupational
Risk of HIV Infection. Arch Intern Med.1993; 153:1451
-8.[Abstract/Free Full Text]
- Henderson DK, Fahey BJ, Willy M,
Schmitt JM, Carey K, Koziol DE, Lane HC, Fedio J, Saah AJ. Risk for
occupational transmission of human immunodeficiency virus type 1 (HIV-1)
associated with clinical exposures. A prospective evaluation. Ann
Intern Med. 1990;113:740
-6.
- Cardo DM, Culver DH, Ciesielski CA,
Srivastava PU, Marcus R, Abiteboul D, Heptonstall J, Ippolito G, Lot F,
McKibben PS, Bell DM. A case-control study of HIV seroconversion in health
care workers after percutaneous exposure. Centers for Disease Control and
Prevention Needlestick Surveillance Group. N Engl J
Med. 1997;337:1485
-90.[Abstract/Free Full Text]
- Liuzzi G, Chirianni A, Clementi M,
Bagnarelli P, Valenza A, Cataldo PT, Piazza M. Analysis of HIV-load in
blood, semen and saliva: evidence for different viral compartments in a
cross-sectional and longitudinal study. AIDS.1996; 10:F51
-6.[Medline]
- Ho DD, Moudgil T, Alam M.
Quantitation of human immunodeficiency virus type 1 in the blood of infected
persons. N Engl J Med.1989; 321:1621
-5.[Abstract]
- U.S. Public Health Service.
Updated U.S. Public Health Service guidelines for the management of
occupational exposures to HBV, HCV, and HIV and recommendations for
postexposure prophylaxis. MMWR Recomm Rep.2001; 50:1
-52.[Medline]
- Centers for Disease Control and
Prevention. Updated interim domestic infection control
precautions for aerosol-generating procedures on patients with severe acute
respiratory syndrome (SARS). January 8, 2004.
www.cdc.gov/ncidod/sars/aerosolinfectioncontrol.htm.
- Kennedy DA. Detection of surface
and airborne blood contamination. In: Collins CH, Kennedy DA, editors.
Occupational blood-borne infections: risk and
management. New York: CAB International; 1997. p89
-100.
- Tokars JI, Culver DH, Mendelson MH,
Sloan EP, Farber BF, Fligner DJ, Chamberland ME, Marcus R, McKibben PS, Bell
DM. Skin and mucous membrane contacts with blood during surgical
procedures: risk and prevention. Infect Control Hosp
Epidemiol. 1995;16:703
-11.[Medline]
- Hospital Infection Control Practices Advisory
Committee; Centers for Disease Control and Prevention. Part
II. Recommendations for isolation precautions in hospitals. November 10, 2002.
www.cdc.gov/ncidod/hip/isolat/isopart2.htm.
- Petersen NJ, Bond WW, Favero MS.
Air sampling for hepatitis B surface antigen in a dental operation.
J Am Dent Assoc.1979; 99:465
-7.[Abstract]
- Petersen NJ. An assessment of the
airborne route in hepatitis B transmission. Ann NY Acad
Sci. 1980;353:157
-66.[Medline]
- Jewett DL, Heinsohn P, Bennett C,
Rosen A, Neuilly C. Blood-containing aerosols generated by surgical
techniques: a possible infectious hazard. Am Ind Hyg Assoc
J. 1992;53:228
-31.[Medline]
- Nogler M, Lass-Florl C, Wimmer C,
Bach C, Kaufmann C, Ogon M. Aerosols produced by high-speed cutters in
cervical spine surgery: extent of environmental contamination. Eur
Spine J. 2001;10:274
-7.[Medline]
- Nogler M, Lass-Florl C, Wimmer C,
Mayr E, Bach C, Ogon M. Contamination during removal of cement in revision
hip arthroplasty: a cadaver study using ultrasound and high-speed cutters.
J Bone Joint Surg Br.2003; 85:436
-9.
- Heinsohn P, Jewett DL. Exposure
to blood-containing aerosols in the operating room: a preliminary study.
Am Ind Hyg Assoc J.1993; 54:446
-53.[Medline]
- Johnson GK, Robinson WS. Human
immunodeficiency virus-1 (HIV-1) in the vapors of surgical power instruments.
J Med Virol.1991; 33:47
-50.[Medline]
- Ehrenkranz NJ, Kicklighter JL.
Tuberculosis outbreak in a general hospital: evidence for airborne spread of
infection. Ann Intern Med.1972; 77:377
-82.
- Frampton MW. An outbreak of
tuberculosis among hospital personnel caring for a patient with a skin ulcer.
Ann Intern Med.1992; 117:312
-3.
- Hutton MD, Stead WW, Cauthen GM,
Bloch AB, Ewing WM. Nosocomial transmission of tuberculosis associated
with a draining abscess. J Infect Dis.1990; 161:286
-95.[Medline]
- Raffalli J, Sepkowitz KA, Armstrong
D. Community-based outbreaks of tuberculosis. Arch Intern
Med. 1996;156:1053
-60.[Abstract/Free Full Text]
- Craven RB, Wenzel RP, Atuk N.
Minimizing tuberculosis risk to hospital personnel and students exposed to
unsuspected disease. Ann Intern Med.1975; 82:628
-32.
- Donnelly CA, Ghani AC, Leung GM,
Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho LM, Thach TQ, Chau P, Chan KP,
Lam TH, Tse LY, Tsang T, Liu SH, Kong JH, Lau EM, Ferguson NM, Anderson
RM. Epidemiological determinants of spread of causal agent of severe acute
respiratory syndrome in Hong Kong. Lancet.2003; 361: 1761-6.
Erratum in: Lancet. 2003;361:1832.[Medline]
- Seto WH, Tsang D, Yung RW, Ching TY,
Ng TK, Ho M, Ho LM, Peiris JS; Advisors of Expert SARS Group of Hospital
Authority. Effectiveness of precautions against droplets and contact in
prevention of nosocomial transmission of severe acute respiratory syndrome
(SARS). Lancet.2003; 361:1519
-20.[Medline]
- Peiris JS, Chu CM, Cheng VC, Chan KS,
Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ,
Ng WL, Lai RW, Guan Y, Yuen KY; HKU/UCH SARS Study Group. Clinical
progression and viral load in a community outbreak of coronavirus-associated
SARS pneumonia: a prospective study. Lancet.2003; 361:1767
-72.[Medline]
- World Health Organization. First
data on stability and resistance of SARS coronavirus compiled by members of
WHO laboratory network.
www.who.int/csr/sars/survival_2003_05_04/en.
- Drosten C, Gunther S, Preiser W, van
der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier
RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme
S, Manuguerra JC, Muller S, Rickerts V, Stormer M, Vieth S, Klenk HD,
Osterhaus AD, Schmitz H, Doerr HW. Identification of a novel coronavirus
in patients with severe acute respiratory syndrome. N Engl J
Med. 2003;348:1967
-76.[Abstract/Free Full Text]
- Centers for Disease Control and
Prevention. Update: outbreak of severe acute respiratory
syndromeworldwide, 2003. MMWR Morb Mortal Wkly
Rep. 2003;52:269
-72.[Medline]
- Department of Health, Hong Kong.
Outbreak of severe acute respiratory syndrome (SARS) at Amoy Gardens, Kowloon
Bay, Hong Kong. Main findings of the investigation. April 17, 2003.
www.info.gov.hk/info/ap/pdf/amoy_e.pdf.
- World Health Organization. Case
definitions for surveillance of severe acute respiratory syndrome (SARS). May
1, 2003.
www.who.int/csr/sars/casedefinition/en/.
- Wong KC, Leung KS, Hui M. Severe
acute respiratory syndrome (SARS) in a geriatric patient with hip fracture. A
case report. J Bone Joint Surg Am.2003; 85:1339
-42.[Free Full Text]
- Fisher DA, Lim TK, Lim YT, Singh KS,
Tambyah PA. Atypical presentations of SARS.
Lancet. 2003;361:1740
.[Medline]
- Centers for Disease Control and
Prevention. Severe acute respiratory
syndromeSingapore, 2003. MMWR Morb Mortal Wkly
Rep. 2003;52:405
-11.[Medline]
- Hong Kong Geriatrics Society.
Severe acute respiratory syndrome (SARS) in elders, 2003 25 April.
www.hkgs.org.hk/sars(eng).pdf.
- Spurgeon D. Toronto succumbs to
SARS a second time. BMJ.2003; 326:1162
.[Free Full Text]
- Centers for Disease Control and
Prevention. Public health guidance for community-level
preparedness and response to severe acute respiratory syndrome (SARS). Version
2. January 8, 2004.
www.cdc.gov/ncidod/sars/guidance/.
- Garner JS. Guideline for
isolation precautions in hospitals. The Hospital Infection Control Practices
Advisory Committee. Infect Control Hosp Epidemiol.1996; 17: 53-80.
Erratum in: Infect Control Hosp Epidemiol. 1996;17:214.[Medline]
- Larson E. A causal link between
handwashing and risk of infection? Examination of the evidence.
Infect Control.1988; 9:28
-36.[Medline]
- Larson E. Skin hygiene and
infection prevention: more of the same or different approaches?
Clin Infect Dis.1999; 29:1287
-94.[Medline]
- Pittet D, Hugonnet S, Harbarth S,
Mourouga P, Sauvan V, Touveneau S, Perneger TV. Effectiveness of a
hospital-wide programme to improve compliance with hand hygiene. Infection
Control Programme. Lancet. 2000;356
: 1307-12. Erratum in:
Lancet. 2000;356:2196.[Medline]
- Larson EL, Early E, Cloonan P, Sugrue
S, Parides M. An organizational climate intervention associated with
increased handwashing and decreased nosocomial infections. Behav
Med. 2000;26:14
-22.[Medline]
- Galle PC, Homesley HD, Rhyne AL.
Reassessment of the surgical scrub. Surg Gynecol
Obstet. 1978;147:215
-8.[Medline]
- O'Farrell DA, Kenny G, O'Sullivan M,
Nicholson P, Stephens M, Hone R. Evaluation of the optimal hand-scrub
duration prior to total hip arthroplasty. JHosp
Infect. 1994;26:93
-8.[Medline]
- Hingst V, Juditzki I, Heeg P, Sonntag
HG. Evaluation of the efficacy of surgical hand disinfection following a
reduced application time of 3 instead of 5min. J Hosp
Infect. 1992;20:79
-86.[Medline]
- Wheelock SM, Lookinland S. Effect
of surgical hand scrub time on subsequent bacterial growth. AORN
J. 1997;65:1087
-92,1094-8.[Medline]
- Larson EL, Aiello AE, Heilman JM,
Lyle CT, Cronquist A, Stahl JB, Della-Latta P. Comparison of different
regimens for surgical hand preparation. AORN J.2001; 73:412
-4,417-8,420 passim.[Medline]
- Mulberrry G, Snyder AT, Heilman J,
Pyrek J, Stahl J. Evaluation of a waterless, scrubless chlorhexidine
gluconate/ethanol surgical scrub for antimicrobial efficacy. Am J
Infect Control. 2001;29:377
-82.[Medline]
- Loeb MB, Wilcox L, Smaill F, Walter
S, Duff Z. A randomized trial of surgical scrubbing with a brush compared
to antiseptic soap alone. Am J Infect Control.1997; 25:11
-5.[Medline]
- Doebbeling BN, Stanley GL, Sheetz CT,
Pfaller MA, Houston AK, Annis L, Li N, Wenzel RP. Comparative efficacy of
alternative hand-washing agents in reducing nosocomial infections in intensive
care units. N Engl J Med.1992; 327:88
-93.[Abstract]
- Massanari RM, Hierrholzer WJ Jr.
A crossover comparison of antiseptic soaps on nosocomial infections rates in
intensive care units. Am J Infect Control.1984; 12:247
-8.
- Parienti JJ, Thibon P, Heller R, Le
Roux Y, von Theobald P, Bensadoun H, Bouvet A, Lemarchand F, Le Couter X,
Bensadoun H; Antisepsie Chirurgicale des Mains Study Group. Hand-rubbing
with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and
30-day surgical site infection rates: a randomized equivalence study.
JAMA. 2002;288:722
-7. Erratum in: JAMA.
2002;288:2689.[Abstract/Free Full Text]
- Rotter ML, Simpson RA, Koller W.
Surgical hand disinfection with alcohols at various concentrations: parallel
experiments using the new proposed European standards method.
Infect Control Hosp Epidemiol.1998; 19:778
-81.[Medline]
- Pietsch H. Hand antiseptics: rubs
versus scrubs, alcoholic solutions versus alcoholic gels. J Hosp
Infect. 2001;48 Suppl A:S33
-6.
- Boyce JM, Pittet D; Healthcare
Infection Control Practices Advisory Committee; HICPA/SHEA/APIC/IDSA Hand
Hygiene Task Force. Guideline for hand hygiene in health-care settings.
Recommendations of the Healthcare Infection Control Practices Advisory
Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for
Healthcare Epidemiology of America/Association for Professionals in Infection
Control/Infectious Diseases Society of America. MMWR Recomm
Rep. 2002;51:1
-45.[Medline]
- Department of Labor, Occupational Safety and Health
Administration. Occupational exposure to bloodborne
pathogens; final rule. Federal Register.1991; 56:64175
-82.
- Tanner J, Parkinson H. Double
gloving to reduce surgical cross-infection. Cochrane Database Syst
Rev. 2002;3:CD003087
.
- Jackson EM, Neal JG, Williams FM,
Stern CA, Suber F, Thacker JG, Edlich RF. Biomechanical performance of
orthopedic gloves. J Biomed Mater Res.1999; 48:193
-8.[Medline]
- Watts D, Tassler PL, Dellon AL.
The effect of double gloving on cutaneous sensibility, skin compliance and
suture identification. Contemp Orthop.1994; 29:407
-11.
- Bell KM, Clement DA. Eye
protection for the surgeon. JR Coll Surg Edinb.1991; 36:178
-9.
- Hubble MJ, Weale AE, Perez JV, Bowker
KE, MacGowan AP, Bannister GC. Clothing in laminar-flow operating
theatres. J Hosp Infect.1996; 32:1
-7.[Medline]
- Whyte W, Hodgson R, Tinkler J.
The importance of airborne bacterial contamination of wounds. J
Hosp Infect. 1982;3:123
-35.[Medline]
- Der Tavitian J, Ong SM, Taub NA,
Taylor GJ. Body-exhaust suit versus occlusive clothing. A randomised,
prospective trial using air and wound bacterial counts. J Bone
Joint Surg Br. 2003;85:490
-4.
- Pasquarella C, Pitzurra O, Herren T,
Poletti L, Savino A. Lack of influence of body exhaust gowns on aerobic
bacterial surface counts in a mixed-ventilation operating theatre. A study of
62 hip arthroplasties. J Hosp Infect.2003; 54:2
-9.[Medline]
- Bohn WW, McKinsey DS, Dykstra M,
Koppe S. The effect of a portable HEPA-filtered body exhaust system on
airborne microbial contamination in a conventional operating room.
Infect Control Hosp Epidemiol.1996; 17:419
-22.[Medline]
- Leonas KK, Jinkins RS. The
relationship of selected fabric characteristics and the barrier effectiveness
of surgical gown fabrics. Am J Infect Control.1997; 25:16
-23.[Medline]
- Granzow JW, Smith JW, Nichols RL,
Waterman RS, Muzik AC. Evaluation of the protective value of hospital
gowns against blood strike-through and methicillin-resistant Staphylococcus
aureus penetration. Am J Infect Control.1998; 26:85
-93.[Medline]
- Centers for Disease Control and
Prevention. Guidelines for preventing the transmission of
Mycobacterium tuberculosis in health-care facilities, 1994. MMWR
Recomm Rep. 1994;43:1
-132.[Medline]
- Chen CC, Willeke K. Aerosol
penetration through surgical masks. Am J Infect
Control. 1992;20:177
-84.[Medline]
- Weber A, Willeke K, Marchioni R,
Myojo T, McKay R, Donnelly J, Liebhaber F. Aerosol penetration and leakage
characteristics of masks used in the health care industry. Am J
Infect Control. 1993;21:167
-73.[Medline]
- Department of Health and Human
Services. Respiratory protective devices final rules and
notice (42 CFR, part 84). Federal Register.1995; 60:30335
-98.
- Nicas M. Respiratory protection
and the risk of Mycobacterium tuberculosis infection. Am J Ind
Med. 1995;27:317
-33.[Medline]
- Mast ST, Woolwine JD, Gerberding
JL. Efficacy of gloves in reducing blood volumes transferred during
simulated needlestick injury. J Infect Dis.1993; 168:1589
-92.[Medline]
- Larson E. Guideline for use of
topical antimicrobial agents. Am J Infect Control.1988; 16:254
-66.
- Widmer AF. Replace hand washing
with use of a waterless alcohol hand rub? Clin Infect
Dis. 2000;31:136
-43.[Medline]

CiteULike Connotea Del.icio.us Technorati What's this?
|